Test description
Specific pathogenic variants in BRAF, NRAS,KIT, GNAQ, GNA11 are of diagnostic significance in various melanomas. Fusionsin ALK, ROS1, NTRK, MET and BRAF are seen in Spitzoid neoplasms along with HRAS mutations.
Test information
Expanded Melanocytic Tumour Panel
Specific pathogenic variants in BRAF, NRAS, KIT, GNAQ, GNA11 are of diagnostic significance in various melanomas.
Fusions in ALK, ROS1, NTRK, MET and BRAF are seen in Spitzoid neoplasms along with HRAS mutations
DNA: BRAF, KIT, NRAS, GNAQ, GNA11, HRAS
RNA: ALK fusion, RET fusion, ROS1 fusion, NTRK fusion, MET fusion, BRAF fusion
NGS Oncomine Precision Assay
5 business days from receipt of sample
N/A
DNA only: $425
DNA & RNA: $799
Somatic Genetic Testing Request Form
FFPE Tumour Tissue
6 x 5µm slides plus 1 x H&E-stained slide required